Reported to Senate with amendment(s)Sep 22, 199201
Extends the patent for the drug Ansaid for 24 months.
Bill102th CongressFiled May 23, 1991Commerce
S. 1165
A bill to extend the patent term of certain products.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary reported to senate with amendment(s) (Sep 22, 1992)
Extends the patent for the drug Ansaid for 24 months.
What just happenedSep 22, 1992
Placed on Senate Legislative Calendar under General Orders. Calendar No. 695.
Who’s behind it
Sen. Levin, Carl [D-MI](D-MI)Sponsor
3 cosponsors2 D1 R
3cosponsors1committees9actions1related bills4subjects
- Sep 22, 1992Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 695.
- Sep 22, 1992Committee
Committee on Judiciary. Reported to Senate by Senator Biden with an amendment in the nature of a substitute and an amendment to the title. With written report No. 102-414.
Judiciary Committee - Sep 22, 1992Committee14000
Committee on Judiciary. Reported to Senate by Senator Biden with an amendment in the nature of a substitute and an amendment to the title. With written report No. 102-414.
Judiciary Committee - Aug 12, 1992Committee
Committee on Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Judiciary Committee - May 21, 1992Committee
Subcommittee on Patents, Copyrights and Trademarks. Approved for full committee consideration with an amendment in the nature of a substitute favorably.
Patents, Copyrights and Trademarks Subcommittee - Aug 1, 1991Committee
Subcommittee on Patents, Copyrights and Trademarks. Hearings held. Hearings printed: S.Hrg. 102-824.
Patents, Copyrights and Trademarks Subcommittee - Jun 7, 1991Committee
Referred to Subcommittee on Patents, Copyrights and Trademarks.
Patents, Copyrights and Trademarks Subcommittee - May 23, 1991IntroReferral
Read twice and referred to the Committee on Judiciary.
Judiciary Committee - May 23, 1991IntroReferral10000
Introduced in Senate
Introduced in SenateMay 23, 199100
Amends Federal patent law to extend the patent term for certain drugs composed of non-steroidal anti-inflammatory agents if during the regulatory review process: (1) the patentee filed a new drug application in 1982; (2) the patentee awaited approval by the Food and Drug Administration for at least 78 months; and (3) such new drug application was approved in 1988. Prescribes a formula for patent term extension, and sets forth administrative notification procedures.